Davy James, Associate Editor

Researchers determine there may be an opportunity to reduce chemotherapy in pediatric patients with hepatoblastoma.

Study examines use of nonsteroidal anti-inflammatory drugs in halting the development of colorectal cancer.

Discovery may lead to better treatments for the virus.

Investigational medication may lead to a promising future for the treatment of the disease.

Filoviruses such as the Ebola and Marburg viruses edit the genetic material of the individuals they infect, according to the results of a recent study.

Ramucirumab approved as a single-agent treatment and in combination with chemotherapy.

Treatment developed by Amgen fails to demonstrate statistically significant improvement in overall survival.

Rx Response addresses the need for clear information to flow to community and retail pharmacies.

An experimental ovarian cancer treatment failed to demonstrate statistically significant improvements in overall survival during a phase 3 trial.

With concerns of a potential Ebola outbreak in the United States still heightened, a pharmaceutical disaster response group is readying pharmacists with a series of resources on the virus.

Following completion of phase 2 trial, phase 3 enrollment expected to start by end of the year.

Low or declining enterovirus D-68 activity reported in 39 states.

An investigational HIV drug developed by Merck exhibited a strong overall safety and efficacy profile in a recently completed phase 2b study.

The severe respiratory illness that infected more than 1000 children across the United States is starting to wane.

New mouse model expected to play significant role in testing vaccines and determining genetic markers for virus.

QmedRx Vice President of Formulations Scott Karolchyk discusses the resurgence of compounding pharmacies.

One of the most crucial roles in the fight to stop the spread of Ebola may be played by a mouse.

T-cell immunotherapy enables stem cell transplants using partially mismatched family members as donors.

Discovery offers potential target for future HIV treatments.

Patients with early stage tumors fare worse with erlotinib than if they take nothing.

Large increase reported in number of African health care workers infected with virus.

Transmission of the Ebola virus remains widespread in West Africa, with infections among health care workers continuing to rise.

Bortezomib found to effectively treat chronic graft-versus-host disease.

Production capacity to be expanded for millions of doses to be available during 2015.

The World Health Organization convened a high-level emergency meeting with government leaders and pharmaceutical company representatives earlier this week to discuss issues surrounding access to experimental Ebola vaccines.

Methotrexate injection treats patients with rheumatoid arthritis, polyarticular-course juvenile idiopathic arthritis, and psoriasis.

New recommendations for the removal of protective gear highlight the need for enhanced technologies.

New recommendations for the removal of protective gear highlight the need for enhanced technologies.

Sovriad found to have caused significant increase in blood bilirubin levels in deceased patients.

More than 1000 cases of enterovirus D68 have now been reported across 47 states.